Contraceptive Market Size and Scope 2026 to 2035
What is Contraceptive Market Size?
Global Contraceptive Market Size is valued at USD 34.43 Billion in 2025 and is predicted to reach USD 75.69 Billion by the year 2035 at a 8.3% CAGR during the forecast period for 2026 to 2035.
Contraceptive Market Size, Share & Trends Analysis Report By Product( Contraceptive Drugs(Contraceptive Pills, Patch, Injectables), Contraceptive Devices(Condoms(Male Condoms, Female Condoms), Subdermal Implants, IUDs(Copper IUDs, Hormonal IUDs), Vaginal Rings, Diaphragm), By Region, And Segment Forecasts, 2026 to 2035
Contraceptive Market Key Takeaways:
|
The use of contraception has increased, which has improved health outcomes, such as maternal and newborn mortality, and reduced the risk of STDs. Additionally, it is projected that an increase in the number of gynecologists who support these contraceptive methods for birth control would fuel business expansion in the coming years. The market projections for contraceptives consider factors such as rising awareness of modern contraceptives, rising use of secure and reliable oral pills, and health concerns associated with teen pregnancies. Female contraceptives currently dominate the market, but as more men use condoms, the demand for male contraceptives will rise.
Serious adverse effects include liver diseases, gallbladder illness, heart attacks, and blood clots in the legs. Over the foreseeable period, sales will be constrained by these contraceptive-related side effects. The market may be expanding due to various issues, such as increased consumer knowledge of STDs, unwanted pregnancies, and population control. These factors will cause the need for contraceptives to skyrocket, especially in emerging nations. There is a considerable likelihood that the market will expand thanks to the arrival of new vendors and the growing accessibility of sophisticated contraception techniques greatly. Retail pharmacies will continue to dominate the industry due to manufacturers' improved supply chain networks.
Competitive Landscape
Some major key players in the Contraceptive market are
- Bayer AG
- China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
- Cupid Ltd.
- Helm AG
- Church & Dwight
- Organon Group Of Companies
- Pfizer Inc.
- Viatris (Mylan)
- Abbvie, Inc.
- Afaxys, Inc.
- Agile Therapeutics
- Janssen Pharmaceuticals, Inc.
- Veru, Inc.
- Others
Market Segmentation:
The contraceptive market is segmented into Products (drugs and devices). Based on drugs, the market is segmented into oral contraceptive pills, injectable contraceptives and topical contraceptives. Based on devices, the contraceptive market is segmented into condoms (male, female), diaphragms, contraceptive sponges, vaginal rings, subdermal implants and intra-uterine devices (copper, hormonal).
Based on contraceptive drugs, the contraceptive pills segment is a major contributor to the Contraceptive market.
The market's leading segment is contraceptive pills. The main purposes of contraception pills are to prevent unintended pregnancies, regulate birth rates, and reduce the risk of sexually transmitted diseases. As a result, it will increase in the years to come. Additionally, rising contraceptive use among young women and higher education levels supports the growth of the contraceptive drugs market.
The vaginal ring segment witnessed growth at a rapid rate
The vaginal ring segment is predicted to develop significantly during the forecast period. The segment is growing due to factors including cost-effectiveness and long product life cycles. The availability of new goods and the simplicity of using vaginal rings are anticipated to increase demand for these birth control methods.
The North American contraceptive market holds a significant revenue share in the region.
The North American Contraceptive market is expected to register the highest market share. Favourable government programs, a high proportion of unwanted pregnancies, a rise in the prevalence of sexually transmitted illnesses, etc. The U.S. government has launched several education campaigns about family planning and contraception, which have boosted the sector's income.
In the United States, there are many unwanted pregnancies. Besides, Asia Pacific had a substantial share of the Contraceptive market. The region's demand for contraceptives is expected to grow due to increased government activities. The market in the Asia Pacific is also anticipated to be driven by an increase in unwanted pregnancies and improved family planning awareness.
Contraceptive Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 34.43 Billion |
| Revenue Forecast In 2035 | USD 75.69 Billion |
| Growth Rate CAGR | CAGR of 8.0% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn, and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product (Drugs and devices) |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Bayer AG; China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu); Cupid Ltd.; Helm AG; Church & Dwight; Organon Group Of Companies; Pfizer Inc.; Viatris (Mylan); Abbvie, Inc.; Afaxys, Inc.; Agile Therapeutics; Janssen Pharmaceuticals, Inc.; Veru, Inc. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation Contraceptive Market :
Contraceptive Market, By Products-
- Contraceptive Drugs
- Contraceptive Pills
- Patch
- Injectables
- Contraceptive Devices
- Condoms
- Male Condoms
- Female Condoms
- Subdermal Implants
- IUDs
- Copper IUDs
- Hormonal IUDs
- Vaginal Rings
- Diaphragm
- Condoms
Contraceptive Market, By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Contraceptive Market Size is valued at USD 34.43 Billion in 2025 and is predicted to reach USD 75.69 Billion by the year 2035
Contraceptive Market expected to grow at a 8.3% CAGR during the forecast period for 2026 to 2035
Bayer AG; China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu); Cupid Ltd.; Helm AG; Church & Dwight; Organon Group Of Companies; Pfizer Inc.; Viatris (Mylan); Abbvie, Inc.; Afaxys, Inc.; Agile Therapeutics; Janssen Pharmaceuticals, Inc.; Veru, Inc. and Others.
Product (Drugs and devices) are the key segments of the Contraceptive Market.
North America region is leading the Contraceptive Market.